Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

ACRAF patents DNA gyrase and DNA topoisomerase IV inhibitors

June 30, 2016

Ablynx to license FOX technology for study of inhaled anti-RSV nanobody

June 29, 2016

Cempra submits solithromycin MAA to EMA

June 29, 2016

FDA approves Epclusa as pan-genotypic single-tablet regimen for chronic HCV infection

June 29, 2016

Bacillus anthracis capsule conjugate vaccine protects rhesus macaques against inhalational anthrax

June 29, 2016

Hookipa Biotech initiates first-in-human study of HB-101 vaccine for CMV

June 29, 2016

Spero Therapeutics presents new MvfR inhibitor for P. aeruginosa infections

June 28, 2016

European Commission approves Zavicefta for serious bacterial infections

June 28, 2016

Carbavance meets primary endpoints in phase III TANGO 1 study in patients with cUTI

June 28, 2016

Shanghai Sun-Sail Pharmaceutical Science & Technology describes antituberculosis compounds

June 28, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...